Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Ductal Carcinoma-Breast. Found 12 abstracts

Lamb EP, Pritchard FE, Nouer SS, Tolley EA, Boyd BS, Davidson JT, Munene G, Fleming MD. Understanding Disparities in Breast Cancer Care in Memphis, Tennessee. Am Surg. 2018 May;84(5):620-7.
Winn JS, Baker MG, Fanous IS, Slack-Davis JK, Atkins KA, Dillon PM. Lobular Breast Cancer and Abdominal Metastases: A Retrospective Review and Impact on Survival. Oncology. 2016 Jan;91(3):135-42.
Burness ML, Obeid EI, Olopade OI. Triple negative breast cancer in BRCA1 mutation carriers with a complete radiologic response to neoadjuvant paclitaxel: a case report. Clin Breast Cancer. 2015 Apr;15(2):e155-8.
Ali SM, Alpaugh RK, Downing SR, Stephens PJ, Yu JQ, Wu H, Buell JK, Miller VA, Lipson D, Palmer GA, Ross JS, Cristofanilli M. Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy. J Clin Oncol. 2014 Sep;32(25):e88-91.   PMCID: 4876358
Kuchenbaecker KB, Neuhausen SL, Robson M, Barrowdale D, McGuffog L, Mulligan AM, Andrulis IL, Spurdle AB, Schmidt MK, Schmutzler RK, Engel C, Wappenschmidt B, Nevanlinna H, Thomassen M, Southey M, Radice P, Ramus SJ, Domchek SM, Nathanson KL, Lee A, Healey S, Nussbaum RL, Rebbeck TR, Arun BK, James P, Karlan BY, Lester J, Cass I, Terry MB, Daly MB, Goldgar DE, Buys SS, Janavicius R, Tihomirova L, Tung N, Dorfling CM, van Rensburg EJ, Steele L, v OH, Ejlertsen B, Gerdes AM, Nielsen FC, Dennis J, Cunningham J, Hart S, Slager S, Osorio A, Benitez J, Duran M, Weitzel JN, Tafur I, Hander M, Peterlongo P, Manoukian S, Peissel B, Roversi G, Scuvera G, Bonanni B, Mariani P, Volorio S, Dolcetti R, Varesco L, Papi L, Tibiletti MG, Giannini G, Fostira F, Konstantopoulou I, Garber J, Hamann U, Donaldson A, Brewer C, Foo C, Evans DG, Frost D, Eccles D, Douglas F, Brady A, Cook J, Tischkowitz M, Adlard J, Barwell J, Ong KR, Walker L, Izatt L, Side LE, Kennedy MJ, Rogers MT, Porteous ME, Morrison PJ, Platte R, Eeles R, Davidson R, Hodgson S, Ellis S, Godwin AK, Rhiem K, Meindl A, Ditsch N, Arnold N, Plendl H, Niederacher D, Sutter C, Steinemann D, Bogdanova-Markov N, Kast K, Varon-Mateeva R, Wang-Gohrke S, Gehrig A, Markiefka B, Buecher B, Lefol C, Stoppa-Lyonnet D, Rouleau E, Prieur F, Damiola F, Barjhoux L, Faivre L, Longy M, Sevenet N, Sinilnikova OM, Mazoyer S, Bonadona V, Caux-Moncoutier V, Isaacs C, Van Maerken T, Claes K, Piedmonte M, Andrews L, Hays J, Rodriguez GC, Caldes T, de la Hoya M, Khan S, Hogervorst FB, Aalfs CM, de Lange JL, Meijers-Heijboer HE, van der Hout AH, Wijnen JT, van Roozendaal KE, Mensenkamp AR, van den Ouweland AM, van Deurzen CH, van der Luijt RB, Olah E, Diez O, Lazaro C, Blanco I, Teule A, Menendez M, Jakubowska A, Lubinski J, Cybulski C, Gronwald J, Jaworska-Bieniek K, Durda K, Arason A, Maugard C, Soucy P, Montagna M, Agata S, Teixeira MR, Olswold C, Lindor N, Pankratz VS, Hallberg E, Wang X, Szabo CI, Vijai J, Jacobs L, Corines M, Lincoln A, Berger A, Fink-Retter A, Singer CF, Rappaport C, Kaulich DG, Pfeiler G, Tea MK, Phelan CM, Mai PL, Greene MH, Rennert G, Imyanitov EN, Glendon G, Toland AE, Bojesen A, Pedersen IS, Jensen UB, Caligo MA, Friedman E, Berger R, Laitman Y, Rantala J, Arver B, Loman N, Borg A, Ehrencrona H, Olopade OI, Simard J, Easton DF, Chenevix-Trench G, Offit K, Couch FJ, Antoniou AC. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2014 Jan;16(6):3416.   PMCID: PMC4406179
Rinella ES, Shao Y, Yackowski L, Pramanik S, Oratz R, Schnabel F, Guha S, LeDuc C, Campbell CL, Klugman SD, Terry MB, Senie RT, Andrulis IL, Daly M, John EM, Roses D, Chung WK, Ostrer H. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Hum Genet. 2013 May;132(5):523-36.
Turaka A, Parsons RB, Buyyounouski MK. Radiation therapy for pituitary metastasis: report of four cases. Tumori. 2012 Jan;98(1):e1-6.   PMCID: Not NIH funded
Badve SS, Baehner FL, Gray RP, Childs BH, Maddala T, Liu ML, Rowley SC, Shak S, Perez EA, Shulman LJ, Martino S, Davidson NE, Sledge GW, Goldstein LJ, Sparano JA. Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. Journal of Clinical Oncology. 2008 May 20;26(15):2473-81.
Bleicher RJ, Abrahamse P, Hawley ST, Katz SJ, Morrow M. The influence of age on the breast surgery decision-making process. Ann Surg Oncol. 2008 Mar;15(3):854-62.
Russo J, Russo IH. Breast development, hormones and cancer. Advances in experimental medicine and biology. 2008 Jan;630:52-6.
O'Sullivan MJ, Morrow M. Ductal carcinoma in situ--current management. Surgical Clinics of North America. 2007 Apr;87(2):333-51.
Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MR, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC, Whittemore AS. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1863-70.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Ductal Carcinoma-Breast

Ductal Carcinoma-Breast Female Breast Neoplasms Middle Aged genetics Adult pathology Aged Estrogen Receptors Lobular Carcinoma Progesterone Receptors secondary BRCA1 Genes Neoplasm Staging etiology Heterozygote Local Neoplasm Recurrence Mutation ErbB-2 Receptor Retrospective Studies therapeutic use metabolism diagnosis Triple Negative Breast Neoplasms United States drug therapy BRCA2 Genes ethnology Intraductal Carcinoma-Noninfiltrating surgery 80 and over Aged Segmental Mastectomy Inflammatory Breast Neoplasms Mastectomy Carcinoma in Situ therapy Logistic Models Case-Control Studies Age Factors Genetic Predisposition to Disease Antineoplastic Agents Male Young Adult Health Status Disparities Hormonal Antineoplastic Agents methods Randomized Controlled Trials Adenocarcinoma Jews psychology Neoadjuvant Therapy adverse effects Haplotypes Healthcare Disparities Deglutition Disorders Quinazolines Pituitary Neoplasms Cohort Studies European Continental Ancestry Group Tamoxifen Prognosis Oral Contraceptives Adolescent ROC Curve Male Breast Neoplasms Hormones Medical Records Patient Participation Stereotaxic Techniques African Americans BRCA1 Protein Antineoplastic Combined Chemotherapy Protocols Alleles radiotherapy 10540-29-1 (Tamoxifen) X-Ray Computed Tomography Lung Neoplasms Abdominal Neoplasms Evidence-Based Medicine Adjuvant Chemotherapy Neoplastic Stem Cells Genome-Wide Association Study enzymology BRCA2 Protein physiology Immunoenzyme Techniques Headache epidemiology Molecular Targeted Therapy Risk Factors su [Surgery] Population Genetics Human Mammary Glands Fatal Outcome pharmacology Genotype Hormonal) 0 (Antineoplastic Agents Questionnaires Area Under Curve Residual Neoplasm Doxorubicin Disease-Free Survival Hormone-Dependent Neoplasms Adjuvant Chemoradiotherapy Tennessee Dose Fractionation Australia Survival Rate Carcinoma mortality administration & dosage Attitudes Health Knowledge-Practice Lymph Node Excision Non-Small-Cell Lung Carcinoma SEER Program tu [Therapeutic Use] Adjuvant Radiotherapy Risk Assessment Neoplasm Grading Health Services Accessibility Smoking Canada Magnetic Resonance Imaging Decision Making Registries Follow-Up Studies Time Factors Palliative Care Sentinel Lymph Node Biopsy Paclitaxel growth & development Breast Carcinoma In Situ Intensity-Modulated Radiotherapy Confusion Reverse Transcriptase Polymerase Chain Reaction Prospective Studies Single Nucleotide Polymorphism drug effects cytology analysis Diplopia complications
Last updated on Friday, January 03, 2020